Cem Onal

51PUBLICATIONS
104CO-AUTHORS
Decision makingRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Accelerators
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Oct 08, 2026
Multi-institutional Patient-level Comparison of Decipher Genomic Classifier and Artera Multimodal Artificial Intelligence (MMAI) in Prostate Cancer.

|Sep 30, 2026
Determinants of late genitourinary toxicity after definitive radiotherapy with or without intraprostatic simultaneous integrated boost in patients with prior transurethral resection of the prostate.

|Sep 13, 2026
Prognostic Value of MRI-Derived Apparent Diffusion Coefficient in Intermediate-Risk Prostate Cancer Treated With Definitive Radiotherapy.

|Mar 30, 2026
Impact of Intraprostatic Simultaneous Integrated Boost on Long-Term Outcomes in Unfavorable Intermediate-Risk Prostate Cancer Treated With Dose-Escalated Radiotherapy and Short-Term Androgen Deprivation Therapy.

Cem Onal, Aysenur Elmali, Birhan Demirhan

|Dec 16, 2025
Impact of Adjuvant Radiotherapy and Mitotane on Survival in Localized Adrenocortical Carcinoma: A Retrospective Cohort Study.

Aysenur Elmali, Ozan Cem Guler, Gokhan Ozyigit

|Nov 04, 2025
Does transurethral resection of prostate increase toxicity risk after simultaneous integrated boost radiotherapy? A matched cohort study with long-term follow-up.

Aysenur Elmali, Birhan Demirhan, Ozan Cem Guler

Pageof 9

Frequent Collaborators

11 joint publications

Ozan Guler

11 joint publications

Aysenur Elmali

9 joint publications

Birhan Demirhan

4 joint publications

Sezin Yuce Sari